Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UiPath Inc (PATH) vs Schwab US Dividend Equity ETF (SCHD) Price & Performance

UiPath IncTrade
Schwab US Dividend Equity ETFTrade

Price performance (Past 24H)

Key statistics

UiPath Inc vs Schwab US Dividend Equity ETF — how do they compare? UiPath Inc trades at $13.34 (market cap $6.91B), while Schwab US Dividend Equity ETF trades at $33.1 (market cap $110.56B). The key difference: Schwab US Dividend Equity ETF is far larger — about 16× UiPath Inc's market cap, and Schwab US Dividend Equity ETF is trading nearer its 52-week high, UiPath Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold UiPath Inc for 139 Days and Schwab US Dividend Equity ETF for 62 Days on average.

PATHSCHD
Market Cap
$6.91B$110.56B
Volume
34,321,25023,539,168
Sector
TechnologyBroad Market / Factor
52-Week High
$19.29$35.21
52-Week Low
$9.38$26.44
Typical Hold Time
139 Days62 Days
Enterprise Value
$5.70B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

UiPath Inc

UiPath (PATH) trades at $13.07, down 0.23% on the day, amid a bearish technical signal and mixed earnings history. The company shows improving fundamentals with revenue growing from $1.43B in 2025 to a projected $1.7B in 2026, while net income is expected to turn positive. Recent news highlights AI partnerships and product innovations, but the stock faces headwinds from cautious analyst sentiment and technical resistance.

The outlook for PATH is cautiously optimistic, with strong revenue growth and a path to profitability offering upside potential, but risks include execution challenges and competitive pressures. The consensus price target of $15.13 suggests moderate upside from current levels, though investor sentiment remains divided.

Schwab US Dividend Equity ETF

SCHD trades at $32.65, down 0.61% on the day, with a bearish technical signal driven by moving averages. The ETF has outperformed the S&P 500 in 2026, with dividend growth attracting income investors. Recent news highlights its defensive tilt and quality focus amid a market pullback.

Outlook is mixed: strong dividend appeal and low fees support long-term income, but technical weakness and interest rate sensitivity pose near-term risks. Investors should weigh SCHD's consistent payout growth against potential underperformance in rising rate environments.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PATH
47% Buy53% Sell
Avg holding period · 139 Days
SCHD
82% Buy18% Sell
Avg holding period · 62 Days

Top news

Latest headlines on both assets

About UiPath Inc

UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.

Read more on PATH →

About Schwab US Dividend Equity ETF

SCHD is an ETF that tracks the Dow Jones U.S. Dividend 100 Index. It selects high-quality companies with a consistent track record of paying dividends, focusing on financial strength metrics like cash flow to total debt and return on equity, and excluding REITs. The fund aims to provide both income and capital appreciation, making it a popular choice for long-term, dividend-focused investors.

Read more on SCHD →